查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466579

藥物釋放型球市場：按類型、塗層技術和最終用戶分類 - 2024-2030 年全球預測

Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

藥物釋放型球囊市場規模預計2023年為96,584萬美元，預估2024年將達到1,09,831萬美元，2030年將達26,5047萬美元，複合年成長率為15.51%。

藥物釋放型球囊 (DEB) 是創新的醫療設備，設計用於血管成形術以治療狹窄或閉塞的動脈。這種基於導管的技術採用了尖端塗布有抗增殖藥物的球囊。當球囊在受影響的動脈內膨脹時，它會機械地擴張血管，恢復血流並將治療劑直接輸送到動脈壁。這種局部藥物傳輸有助於透過抑制新內膜增生的生長來防止動脈血管再阻塞，新內膜增生是血管再阻塞的常見原因。 DEB 提供了一種標靶藥物方法，可以補充機械干預措施，並為裸金屬支架和藥物釋放型支架等傳統治療方法提供替代方案。藥物釋放型球囊市場的成長主要是由全球心血管疾病盛行率的上升以及隨之而來的微創外科手術需求的增加所推動的。然而，嚴格的監管核准流程可能會阻礙市場成長。此外，新興國家 DEB 治療的高成本可能會抑制潛在市場。儘管面臨挑戰，但提高 DEB 療效和安全性的技術進步以及患者康復時間的延長帶來了未來的市場機會。新興國家增加有利於 DEB 待遇的報銷政策為市場擴張開闢了新途徑。

主要市場統計
基準年[2023] 9.6584億美元
預測年份 [2024] 1,098,310,000 美元
預測年份 [2030] 26.5047億美元
複合年成長率（%） 15.51%

冠狀動脈DEB在改善類型傳遞和藥物轉移的意義

冠狀動脈塗藥氣球(DEB) 是用於經皮冠狀動脈介入治療 (PCI) 治療冠狀動脈疾病的創新醫療設備。 DEB 經過精心設計，可將抗增生藥物直接輸送到動脈阻塞部位，抑制新內膜增生並防止血管再阻塞。週邊藥物釋放型球囊用於治療周邊動脈疾病(PAD)，特別是股動脈和膕動脈。與冠狀動脈類似，這些 DEB 釋放藥物，透過最大限度地減少血管平滑肌組織的增殖來預防血管再阻塞。

包衣技術：越來越偏好具有更好局部藥物釋放特性的EnduraCoat

EnduraCoat技術是一種塗層，旨在提供均勻且受控的藥物向動脈壁的遷移。該技術通常提供耐用的低劑量塗層，最大限度地減少顆粒損失並確保一致的藥物釋放曲線。 FreePac是一種將合成聚合物和抗增殖藥物結合在一起的塗層，可確保穩定的藥物遷移和生物有效性。FreePac通常旨在解決周邊動脈疾病血管再阻塞的挑戰。 Paccocath 技術由封裝在基質內的化療藥物和特定賦形劑的混合物組成。這種基質塗層控制藥物釋放到目標病灶並防止新內膜增生。 TransPax 是一種新型塗層技術，使​​用生物可吸收載體進行藥物傳輸。 TransPax 可能更適合那些受益於生物可吸收藥物輸送系統的患者。當不希望長期存在不可再吸收的聚合物時，該系統可能是有利的。

最終用戶：易用性和程序速度將推動 DEB 在導管實驗室中的採用。

門診手術中心 (ASC) 優先考慮 DEB，因為它們專注於門診手術，其中效率和患者周轉率是關鍵因素。患者受益於 DEB 的微創特性，這與 ASC 縮短住院時間和促進早期復原的模式一致。導管實驗室是進行心導管插入術和其他血管內手術的專門醫院單位或獨立設施。 DEB 在這些中心是首選，因為它可以減少血管再阻塞的機會，而無需長期使用支架。由於提供的服務和處理的患者病例多種多樣，醫院代表了 DEB 最廣泛的最終用戶群體。醫院需要多功能且可用於複雜、高風險患者群體的 DEB。

區域洞察

在美洲，藥物釋放型球囊 (DEB) 市場在多種因素的推動下出現強勁成長，包括周邊動脈疾病和冠狀動脈疾病患病率的上升，以及人們對 DEB 相對於傳統治療方法的優勢的認知不斷提高。美國因其先進的醫療基礎設施、有利的報銷政策以及強大的市場參與者而成為該地區的主要貢獻者。該地區的成長也得到了許多檢驗DEB 療法功效和安全性的臨床試驗和研究的支持。歐洲、中東和非洲地區為 DEB 帶來了多元化的市場格局。 DEB 在歐洲的採用正在加速，特別是在西歐國家，這改善了新醫療設備的取得並增加了老牌公司的存在。在醫療保健基礎設施改善和醫療保健產業投資增加的推動下，中東和非洲呈現出開拓的機遇，持續溫和成長。由於人口快速成長、糖尿病引起的血管疾病發病率增加以及醫療保健成本上升，亞太地區的 DEB 市場顯示出巨大的成長潛力。此外，本地製造商的增加以及政府加強醫療基礎設施的積極努力也刺激了亞太地區市場。

FPNV定位矩陣

FPNV定位矩陣對於評估藥物釋放型球囊市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對藥物釋放型球囊市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.藥物釋放型球市場的市場規模與預測為何？

2.藥物釋放型球市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.藥物釋放型球囊市場的技術趨勢和法規結構是什麼？

4.藥物釋放型球市場主要供應商的市場佔有率為何？

5.進入藥物釋放型球囊市場適合的型態與策略手段有哪些？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人口增加導致心血管疾病
      • 周邊動脈疾病和冠狀動脈疾病的盛行率增加
      • 良好的核准支持 DEB 的發展
    • 抑制因素
      • 與藥物釋放型球囊產品召回相關的問題
    • 機會
      • 藥物塗層球囊導管臨床應用新進展
      • 藥物塗層球囊的進展、創新與研究
    • 任務
      • 缺乏熟練且訓練有素的專業人員
  • 市場區隔分析
    • 類型：冠狀動脈 DEB 在改善遞送和藥物遷移的重要性
    • 包衣技術：enduraCoat 因其卓越的局部藥物釋放特性而越來越受歡迎
    • 最終使用者：易用性和程序速度提高了 DEB 在導管實驗室的採用率。
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章藥物釋放型球市場：依類型

  • 冠狀動脈塗藥氣球
  • 周邊設備藥物釋放型球囊

第7章藥物釋放型球市場：塗層技術

  • EnduraCoat
  • FreePac
  • 帕科卡斯
  • 跨太平洋運輸公司

第8章藥物釋放型球囊市場：依最終用戶分類

  • 門診手術中心
  • 導管實驗室
  • 醫院

第9章美洲藥物釋放型球市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥物釋放型球囊市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲藥物釋放型氣球市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Advanced NanoTherapies (ANT) 獲得 400 萬美元戰略投資，加速 SirPlux Duo 藥物塗層球囊 (DCB) 的臨床開發，用於治療新型冠狀動脈疾病 (CAD)
    • Translumina 透過收購 Dutch Blue Medical Devices 進一步增強技術組合
    • Surmodics 的 SurVeil 藥物塗層球囊獲得 FDA核准

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4348D129FA8E

[198 Pages Report] The Drug Eluting Balloon Market size was estimated at USD 965.84 million in 2023 and expected to reach USD 1,098.31 million in 2024, at a CAGR 15.51% to reach USD 2,650.47 million by 2030.

A drug eluting balloon (DEB) is an innovative medical device designed for use in angioplasty procedures to treat narrowed or blocked arteries. This catheter-based technology incorporates a balloon at its tip, which is coated with an anti-proliferative medication. When the balloon is inflated within the affected artery, it mechanically dilates the vessel to restore blood flow and also delivers the therapeutic agent directly to the arterial walls. This local drug delivery helps prevent restenosis, the re-narrowing of the artery, by inhibiting the growth of neointimal hyperplasia, a common cause of vessel re-occlusion. DEBs provide a targeted pharmacological approach that complements the mechanical intervention, offering an alternative to traditional therapies such as bare-metal or drug-eluting stents. The growth of the drug eluting balloon market is primarily driven by the rising prevalence of cardiovascular diseases globally and the subsequent increase in demand for minimally invasive surgical procedures. However, the stringent regulatory approval processes can impede the market's progression. Additionally, high costs associated with DEB treatments may deter potential markets in developing countries. Despite challenges, technological advancements improving the efficacy and safety of DEBs, along with enhanced patient recovery times, present future market opportunities. Rising reimbursement policies favoring DEB procedures in developing nations create new avenues for market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 965.84 million
Estimated Year [2024] USD 1,098.31 million
Forecast Year [2030] USD 2,650.47 million
CAGR (%) 15.51%

Type: Significance of coronary DEBs in enhancing deliverability and drug transfer

Coronary drug eluting balloons (DEBs) is an innovative medical device used in percutaneous coronary interventions (PCIs) to treat coronary artery disease. They are carefully designed to deliver anti-proliferative drugs directly to the site of arterial blockage, facilitating the inhibition of neointimal hyperplasia and thus preventing restenosis. Peripheral drug eluting balloons are deployed to treat peripheral artery disease (PAD), particularly in the femoral and popliteal arteries. Similar to their coronary counterparts, these DEBs release medication that helps prevent restenosis by minimizing the growth of the vascular smooth muscle tissue.

Coating Technology: Growing preferences for enduraCoat with better local drug release profile

EnduraCoat technology is a coating designed to provide a uniform and controlled drug transfer to the arterial wall. This technology typically offers a durable, low-dose coating that minimizes particulate loss and ensures a consistent drug release profile. FreePac is a type of coating that combines a synthetic polymer and an antiproliferative drug, ensuring consistent drug transfer and bioavailability. FreePac is typically designed to address the challenges of restenosis in peripheral arterial disease. Paccocath technology incorporates a mixture of a chemotherapeutic drug and a specific excipient encapsulated within a matrix. This matrix coating allows for controlled drug release to the target lesion, preventing neointimal hyperplasia. TransPax is a newer coating technology that uses a bioresorbable carrier for drug delivery. TransPax may be preferred for patients who could benefit from a bioresorbable drug delivery system. This system is potentially advantageous where the long-term presence of non-resorbable polymers can be undesirable.

End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure

Ambulatory surgery centers (ASCs) prioritize DEBs owing to their focus on outpatient surgical care, where efficiency and patient turnover are key factors. Patients benefit from the minimally invasive nature of DEB procedures, which aligns with the ASC model of reducing hospital stays and promoting quick recovery. Cath labs are specialized hospital units or stand-alone facilities where cardiac catheterizations and other endovascular procedures are performed. DEBs are preferred in these facilities for their ability to reduce the likelihood of restenosis without the long-term commitment of a stent. Hospitals represent the broadest end-user segment for DEBs owing to the variety of services offered and patient cases handled. Hospitals require DEBs that are versatile and can be used for complex and high-risk patient populations.

Regional Insights

In the Americas, the market for drug-eluting balloons (DEBs) has been experiencing robust growth driven by several factors, including the rising prevalence of peripheral and coronary artery diseases and increased awareness of the benefits of DEBs over traditional therapies. The United States is a major contributor in this region owing to its advanced healthcare infrastructure, favorable reimbursement policies, and presence of significant market players. The region's growth is further supported by numerous clinical trials and research studies validating the efficacy and safety of DEB therapy. The EMEA region presents a diverse market landscape for DEBs. In Europe, the adoption of DEBs is gaining momentum, especially in Western European countries, with higher accessibility to new medical devices and a strong presence of established companies. The Middle East and Africa present untapped opportunities with gradual growth, propelled by improving healthcare infrastructure and increasing investment in the healthcare sector. The Asia-Pacific market for DEBs is showing significant growth potential, with the burgeoning population, the increasing incidence of diabetes-induced vascular diseases, and escalating healthcare expenditures. Moreover, APAC's market is being stimulated by the rising number of local manufacturers and favorable government initiatives to enhance healthcare infrastructure.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Eluting Balloon Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Eluting Balloon Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Balloon Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Balton Sp. z o. o., Bayer AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cardionovum GmbH, Concept Medical, Cook Medical, Inc., Eurocor Tech GmbH, Invamed, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Laborie Medical Technologies, Inc., Lepu Medical Technology, M.A. Med Alliance SA by Cordis Corporation, Medtronic PLC, SurModics, Inc., Terumo Corporation, Wellinq, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Coronary Drug Eluting Balloon
    • Peripheral Drug Eluting Balloon
  • Coating Technology
    • EnduraCoat
    • FreePac
    • Paccocath
    • TransPax
  • End User
    • Ambulatory Surgery Centers
    • Cath Labs
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug Eluting Balloon Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Eluting Balloon Market?

3. What are the technology trends and regulatory frameworks in the Drug Eluting Balloon Market?

4. What is the market share of the leading vendors in the Drug Eluting Balloon Market?

5. Which modes and strategic moves are suitable for entering the Drug Eluting Balloon Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Geriatric Population Leading to Cardiovascular Diseases
      • 5.1.1.2. Rising Prevalence of Peripheral and Coronary Artery Diseases
      • 5.1.1.3. Favorable Approvals to Support the Growth of DEBs
    • 5.1.2. Restraints
      • 5.1.2.1. Issues Associated to Product Recalls of Drug-Eluting Balloons
    • 5.1.3. Opportunities
      • 5.1.3.1. New Developments in the Clinical Use of Drug-Coated Balloon Catheters
      • 5.1.3.2. Advancement, Innovation, and Research in Drug-Coated Balloons
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Availability for Skilled and Trained Professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
    • 5.2.2. Coating Technology: Growing preferences for enduraCoat with better local drug release profile
    • 5.2.3. End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Drug Eluting Balloon Market, by Type

  • 6.1. Introduction
  • 6.2. Coronary Drug Eluting Balloon
  • 6.3. Peripheral Drug Eluting Balloon

7. Drug Eluting Balloon Market, by Coating Technology

  • 7.1. Introduction
  • 7.2. EnduraCoat
  • 7.3. FreePac
  • 7.4. Paccocath
  • 7.5. TransPax

8. Drug Eluting Balloon Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Cath Labs
  • 8.4. Hospitals

9. Americas Drug Eluting Balloon Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Eluting Balloon Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Eluting Balloon Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
    • 12.3.2. Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands
    • 12.3.3. Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG ELUTING BALLOON MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG ELUTING BALLOON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG ELUTING BALLOON MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG ELUTING BALLOON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023